Stoke Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $2.5M | $107.5M | $105.4M |
| FY2019 | $4.3M | $228.8M | $222.5M |
| FY2020 | $11.8M | $297.9M | $287.3M |
| FY2021 | $21.1M | $238.9M | $144.9M |
| FY2022 | $71.2M | $256.1M | $113.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $2.5M | $107.5M | $105.4M |
| FY2019 | $4.3M | $228.8M | $222.5M |
| FY2020 | $11.8M | $297.9M | $287.3M |
| FY2021 | $21.1M | $238.9M | $144.9M |
| FY2022 | $71.2M | $256.1M | $113.6M |